Progress in Neuro-Psychopharmacology and Biological Psychiatry

Editorial Board
pp. CO2-CO2(1)

Residual symptoms in depression - An emerging therapeutic target
pp. 1019-1027(9)
Authors: Fava G.A.; Fabbri S.; Sonino N.

Effects of chronic antidepressants and electroconvulsive shock on serotonergic neurotransmission in the rat hypothalamus
pp. 1029-1034(6)
Authors: Dremencov E.; Gur E.; Lerer B.; Newman M.E.

Clinical outcome of adjunctive topiramate treatment in a sample of refractory bipolar patients with comorbid conditions
pp. 1035-1039(5)
Authors: Guille C.; Sachs G.

Co-occurrence of disturbed sleep and appetite loss differentiates between unipolar and bipolar depressive episodes
pp. 1041-1045(5)
Authors: Papadimitriou G.N.; Dikeos D.G.; Daskalopoulou E.G.; Soldatos C.R.

The effect of chronic treatment with typical and atypical antipsychotics on working memory and jaw movements in three- and eighteen-month-old rats
pp. 1047-1054(8)
Authors: Rosengarten H.; Quartermain D.

Olanzapine for the treatment of chronic refractory schizophrenia - A 12-month follow-up naturalistic study
pp. 1055-1062(8)
Authors: Rodrguez-Perez V.; Lopez A.; Blanco C.; Pena C.; Lopez A.; Abel A.; Gomez Y.; Ferreiro M.J.; Rego C.; Lopez A.; Cudeiro F.; Alvarez V.; Prieto R.; Ciudad A.

Calcium homeostasis in long-term lithium-treated women with bipolar affective disorder
pp. 1063-1069(7)
Authors: El Khoury A.; Petterson U.; Kallner G.; Åberg-Wistedt A.; Stain-Malmgren R.

Clinical phenotyping strategies in selection of tobacco smokers for future genotyping studies
pp. 1071-1078(8)
Authors: Domino E.F.; Ni L.

Syndrome profiles in alcoholism and panic disorder with or without agoraphobia - An explorative family study
pp. 1079-1087(9)
Authors: Davids E.; Muller M.J.; Rollmann N.; Burkart M.; Regier-Klein E.; Szegedi A.; Benkert O.; Maier W.

Effects of fencamfamine on latent inhibition
pp. 1089-1093(5)
Authors: Alves C.R.R.; Delucia R.; Silva M.T.A.

Dopamine D₁ and D₂ receptor mRNA up-regulation in the caudate-putamen and nucleus accumbens of rat brains by smoking
pp. 1095-1104(10)
Authors: Bahk J.Y.; Li S.; Park M.S.; Kim M.O.

Which could be a clinically useful definition of depressive mixed state?
pp. 1105-1111(7)
Author: Benazzi F.

Spatial memory and choice behavior in the radial arm maze after fornix transection
pp. 1113-1123(11)
Authors: Hudon C.; Dore F.Y.; Goulet S.

Involvement of nitric oxide on prolactin release induced by immobilization stress in rats
pp. 1125-1128(4)
Authors: Iuras A.; Nonaka K.O.

Efficacy of venlafaxine in major depression resistant to selective serotonin reuptake inhibitors
pp. 1129-1134(6)
Authors: Saiz-Ruiz J.; Ibanez A.; Daz-Marsa M.; Arias F.; Padn J.; Martn-Carrasco M.; Montes J.M.; Ferrando L.; Carrasco J.L.; Martn-Ballesteros E.; Jorda L.; Chamorro L.

Anxiogenic effect of median raphe nucleus lesion in stressed rats
pp. 1135-1141(7)
Authors: Netto S.M.; Silveira R.; Coimbra N.C.; Joca S.R.L.; Guimaraes F.S.

A preliminary functional magnetic resonance imaging study in offspring of schizophrenic parents
pp. 1143-1149(7)
Authors: Keshavan M.S.; Diwadkar V.A.; Spencer S.M.; Harenski K.A.; Luna B.; Sweeney J.A.

Acute and subchronic effects of MDMA (''ecstasy'') on anxiety in male mice tested in the elevated plus-maze
pp. 1151-1154(4)
Authors: Navarro J.F.; Maldonado E.

Decrease of the D₄ dopamine receptor messenger RNA expression in lymphocytes from patients with major depression
pp. 1155-1160(6)
Authors: Rocca P.; De Leo C.; Eva C.; Marchiaro L.; Milani A.M.; Musso R.; Ravizza L.; Zanalda E.; Bogetto F.

Potentiation of muscimol-induced long-term depression by benzodiazepines but not zolpidem
pp. 1161-1166(6)
Authors: Akhondzadeh S.; Mohammadi M.R.; Kashani L.

Interleukine-6 serum levels correlate with response to antidepressant sleep deprivation and sleep phase advance
pp. 1167-1170(4)
Authors: Benedetti F.; Lucca A.; Brambilla F.; Colombo C.; Smeraldi E.

Effects of electroconvulsive therapy on hypothalamic-pituitary-thyroid axis activity in depressed patients
pp. 1171-1175(5)
Authors: Esel E.; Turan T.; Kula M.; Reyhancan M.; Gonul A.; Basturk M.; Sofuoglu S.

Methamphetamine-induced dopaminergic neurotoxicity in mice - Long-lasting sensitization to the locomotor stimulation and desensitization to the rewarding effects of methamphetamine
pp. 1177-1183(7)
Authors: Itzhak Y.; Martin J.L.; Ali S.F.

Effects of the social conditions of housing through testing on cocaine-induced contextual sensitisation and conditioned locomotion in C57BL/6J mice
pp. 1185-1191(7)
Authors: Michel A.; Tirelli E.

Platelet serotonergic markers in posttraumatic stress disorder
pp. 1193-1198(6)
Authors: Pivac N.; Muck-Seler D.; Sagud M.; Jakovljevic M.

Olanzapine vs. haloperidol in the treatment of elderly chronic schizophrenia patients
pp. 1199-1202(4)
Authors: Barak Y.; Shamir E.; Zemishlani H.; Mirecki I.; Toren P.; Weizman R.

Treatment of acute mania with topiramate in hospitalized patients
pp. 1203-1206(4)
Authors: Bozikas V.P.; Petrikis P.; Kourtis A.; Youlis P.; Karavatos A.

Use of atypical antipsychotics in a Veterans Affairs hospital
pp. 1207-1210(4)
Authors: Schwartz T.L.; Saba M.; Hardoby W.; Virk S.; Masand P.S.

REM sleep latency and wakefulness in the first sleep cycle as markers of major depression - A controlled study vs. schizophrenia and normal controls
pp. 1211-1215(5)
Authors: Rotenberg V.S.; Shamir E.; Barak Y.; Indursky P.; Kayumov L.; Mark M.

Neurocognitive deficits and quality of life in outpatients with schizophrenia
pp. 1217-1219(3)
Authors: Aksaray G.; Oflu S.; Kaptanoglu C.; Bal C.

Topiramate in opiate withdrawal
pp. 1221-1223(3)
Authors: Zullino D.F.; Cottier A.-C.; Besson J.

Neuroleptic malignant syndrome complicated by massive intestinal bleeding in a patient with chronic renal failure
pp. 1225-1227(3)
Authors: Hayashi H.; Kawakatsu S.; Watanabe K.; Fukasawa T.; Otani K.